Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 5/2017

20.01.2017 | Original Article – Clinical Oncology

Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer

verfasst von: Yingchun Li, Chenyu Wang, Mengdan Xu, Cuicui Kong, Aibing Qu, Meng Zhang, Zhichao Zheng, Guirong Zhang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study is to determine the efficacy of adjuvant immunotherapy with autologous cytokine-induced killer (CIK) for postoperative patients with gastric cancer and to investigate the impacts of the predictors on the efficacy of CIK immunotherapy.

Patients and methods

Ninety-two gastric cancer patients who have accepted radical resection were enrolled. The CIK and control groups were established by 1:1 matching on their baseline. As prognosis indicators, preoperative blood cell counts, the neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) were analyzed, respectively. Statistical analyses were done using IBM SPSS Statistics ver.19.0.

Results

CIK treatment significantly prolonged disease-free survival (DFS) (p < 0.05) and there was a tendency of longer overall survival (OS) in the CIK group (p = 0.057). Preoperative NLR was an independent prognostic factor for DFS (p < 0.05). When patients were classified into low and high NLR groups using the cutoff value of 2.995, patients in the low NLR group had a better DFS (p < 0.05). Subset analysis showed that CIK immunotherapy significantly prolonged the DFS in the low NLR group (p = 0.017) but not in the high NLR group (p = 0.695) except that it did well clearly within 17 months. Compared to the low NLR group, lymphocyte decreased significantly, neutrophil increased steeply and white blood cell (WBC) elevated subsequently (p < 0.001in all cases) in the high NLR group.

Conclusion

Adjuvant immunotherapy with the CIK cells prolongs DFS in postoperative patients with gastric cancer and the preoperative NLR is an independent prognostic factor for DFS. Low NLR predicts significant benefits from the CIK immunotherapy while high NLR forebodes the requirement of more cycles of CIK treatment or other stronger immunotherapy to improve the survival rate of patients.
Literatur
Zurück zum Zitat Auphan-Anezin N, Verdeil G, Grange M, Soudja SM, Wehbe M, Buferne M, Mas A, Schmitt-Verhulst AM (2013) Immunosuppression in inflammatory melanoma: can it be resisted by adoptively transferred T cells? Pigment Cell Melanoma Res 26(2):167–75CrossRefPubMed Auphan-Anezin N, Verdeil G, Grange M, Soudja SM, Wehbe M, Buferne M, Mas A, Schmitt-Verhulst AM (2013) Immunosuppression in inflammatory melanoma: can it be resisted by adoptively transferred T cells? Pigment Cell Melanoma Res 26(2):167–75CrossRefPubMed
Zurück zum Zitat Bunt SK, Yang L, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S (2007) Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res 67(20):10019–26CrossRefPubMedPubMedCentral Bunt SK, Yang L, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S (2007) Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res 67(20):10019–26CrossRefPubMedPubMedCentral
Zurück zum Zitat Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015.CA Cancer J Clin 66(2):115–32CrossRefPubMed Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015.CA Cancer J Clin 66(2):115–32CrossRefPubMed
Zurück zum Zitat Coffelt SB, de Visser KE (2014) Cancer: inflammation lights the way to metastasis. Nature 507(7490):48–9CrossRefPubMed Coffelt SB, de Visser KE (2014) Cancer: inflammation lights the way to metastasis. Nature 507(7490):48–9CrossRefPubMed
Zurück zum Zitat De Giorgi U, Mego M, Scarpi E, Giuliano M, Giordano A, Reuben JM, Valero V, Ueno NT, Hortobagyi GN, Cristofanilli M (2012) Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer. Clin Breast Cancer 12(4):264–269CrossRefPubMed De Giorgi U, Mego M, Scarpi E, Giuliano M, Giordano A, Reuben JM, Valero V, Ueno NT, Hortobagyi GN, Cristofanilli M (2012) Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer. Clin Breast Cancer 12(4):264–269CrossRefPubMed
Zurück zum Zitat Donskov F (2013) Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol 23(3):200–207CrossRefPubMed Donskov F (2013) Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol 23(3):200–207CrossRefPubMed
Zurück zum Zitat Gabrilovich D, Pisarev V (2003) Tumor escape from immune response mechanisms and targets of activity. Current Drug Targets 4(7):525–36CrossRefPubMed Gabrilovich D, Pisarev V (2003) Tumor escape from immune response mechanisms and targets of activity. Current Drug Targets 4(7):525–36CrossRefPubMed
Zurück zum Zitat Goode EF, Smyth EC (2016) Immunotherapy for gastroesophageal cancer. J Clin Med 5(10):pii: E84 Goode EF, Smyth EC (2016) Immunotherapy for gastroesophageal cancer. J Clin Med 5(10):pii: E84
Zurück zum Zitat Grenader T, Waddell T, Peckitt C, Oates J, Starling N, Cunningham D, Bridgewater J (2016) Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial. Ann Oncol 27(4):687–692CrossRefPubMed Grenader T, Waddell T, Peckitt C, Oates J, Starling N, Cunningham D, Bridgewater J (2016) Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial. Ann Oncol 27(4):687–692CrossRefPubMed
Zurück zum Zitat Hattar K, Franz K, Ludwig M et al (2014) Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis. Cancer Immunol Immunother 63(12):1297–1306CrossRefPubMedPubMedCentral Hattar K, Franz K, Ludwig M et al (2014) Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis. Cancer Immunol Immunother 63(12):1297–1306CrossRefPubMedPubMedCentral
Zurück zum Zitat Huh SJ, Liang S, Sharma A, Dong C, Robertson GP (2010) Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Res 70(14):6071–82CrossRefPubMedPubMedCentral Huh SJ, Liang S, Sharma A, Dong C, Robertson GP (2010) Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Res 70(14):6071–82CrossRefPubMedPubMedCentral
Zurück zum Zitat Hwang SG, Kim KM, Cheong JH, Kim HI, An JY, Hyung WJ, Noh SH (2012) Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer. Eur J Surg Oncol 38(7):562–567CrossRefPubMed Hwang SG, Kim KM, Cheong JH, Kim HI, An JY, Hyung WJ, Noh SH (2012) Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer. Eur J Surg Oncol 38(7):562–567CrossRefPubMed
Zurück zum Zitat Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H, Masutani S, Tatsuta M, Satomi T (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9(3):287–291CrossRefPubMed Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H, Masutani S, Tatsuta M, Satomi T (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9(3):287–291CrossRefPubMed
Zurück zum Zitat Jäkel CE, Vogt A, Gonzalez-Carmona MA, Schmidt-Wolf IG (2014) Clinical studies applying cytokine-induced killer cells for the treatment of gastrointestinal tumors. J Immunol Res 2014:897214 Jäkel CE, Vogt A, Gonzalez-Carmona MA, Schmidt-Wolf IG (2014) Clinical studies applying cytokine-induced killer cells for the treatment of gastrointestinal tumors. J Immunol Res 2014:897214
Zurück zum Zitat Joo MK, Park JJ, Chun HJ (2016) Recent updates of precision therapy for gastric cancer: towards optimal tailored management. World J Gastroenterol 22(19):4638–50CrossRefPubMedPubMedCentral Joo MK, Park JJ, Chun HJ (2016) Recent updates of precision therapy for gastric cancer: towards optimal tailored management. World J Gastroenterol 22(19):4638–50CrossRefPubMedPubMedCentral
Zurück zum Zitat Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5(10):749–59CrossRefPubMed Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5(10):749–59CrossRefPubMed
Zurück zum Zitat Keizman D, Ish-Shalom M, Huang P, Eisenberger MA, Pili R, Hammers H, Carducci MA (2012) The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma. Eur J Cancer 48(2):202–8CrossRefPubMed Keizman D, Ish-Shalom M, Huang P, Eisenberger MA, Pili R, Hammers H, Carducci MA (2012) The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma. Eur J Cancer 48(2):202–8CrossRefPubMed
Zurück zum Zitat Kiessling R, Wasserman K, Horiguchi S, Kono K, Sjöberg J, Pisa P, Petersson M (1999) Tumor-induced immune dysfunction. Cancer Immunol Immunother 48(7):353–62CrossRefPubMed Kiessling R, Wasserman K, Horiguchi S, Kono K, Sjöberg J, Pisa P, Petersson M (1999) Tumor-induced immune dysfunction. Cancer Immunol Immunother 48(7):353–62CrossRefPubMed
Zurück zum Zitat Kim EY, Lee JW, Yoo HM, Park CH, Song KY (2015) The platelet-to-lymphocyte ratio versus neutrophil-to-lymphocyte ratio: which is better as a prognostic factor in gastric cancer? Ann Surg Oncol 22(13):4363–4370CrossRefPubMed Kim EY, Lee JW, Yoo HM, Park CH, Song KY (2015) The platelet-to-lymphocyte ratio versus neutrophil-to-lymphocyte ratio: which is better as a prognostic factor in gastric cancer? Ann Surg Oncol 22(13):4363–4370CrossRefPubMed
Zurück zum Zitat Kowanetz M, Wu X, Lee J et al (2010) Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+granulocytes. Proc Natl Acad Sci USA 107(50):21248–55CrossRefPubMedPubMedCentral Kowanetz M, Wu X, Lee J et al (2010) Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+granulocytes. Proc Natl Acad Sci USA 107(50):21248–55CrossRefPubMedPubMedCentral
Zurück zum Zitat Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH (2003) Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6(4):283–287CrossRefPubMed Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH (2003) Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6(4):283–287CrossRefPubMed
Zurück zum Zitat Lazăr DC, Tăban S, Cornianu M, Faur A, Goldiş A (2016) New advances in targeted gastric cancer treatment. World J Gastroenterol 22(30):6776–99CrossRefPubMedPubMedCentral Lazăr DC, Tăban S, Cornianu M, Faur A, Goldiş A (2016) New advances in targeted gastric cancer treatment. World J Gastroenterol 22(30):6776–99CrossRefPubMedPubMedCentral
Zurück zum Zitat Lee JH, Lee JH, Lim YS et al (2015) Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma. Gastroenterology 148(7):1383–91.e6CrossRefPubMed Lee JH, Lee JH, Lim YS et al (2015) Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma. Gastroenterology 148(7):1383–91.e6CrossRefPubMed
Zurück zum Zitat Li Y, Jin A, Chen S, Song C, Zhang G (2015) Efficacy of adjuvant chemotherapy combined with CIK cell immunotherapy in 130 patients with postoperative colorectal cancer [in Chinese]. J Chin Oncol 21(10):843–847 Li Y, Jin A, Chen S, Song C, Zhang G (2015) Efficacy of adjuvant chemotherapy combined with CIK cell immunotherapy in 130 patients with postoperative colorectal cancer [in Chinese]. J Chin Oncol 21(10):843–847
Zurück zum Zitat Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics. CA Cancer J Clin 66(4):271–89CrossRefPubMed Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics. CA Cancer J Clin 66(4):271–89CrossRefPubMed
Zurück zum Zitat Nagtegaal ID, Marijnen CA, Kranenbarg EK et al (2001) Local and distant recurrences in rectal cancer patients are predicted by the nonspecificimmune response; specific immune response has only a systemic effect–a histopathological and immunohistochemical study. BMC Cancer 1:7CrossRefPubMedPubMedCentral Nagtegaal ID, Marijnen CA, Kranenbarg EK et al (2001) Local and distant recurrences in rectal cancer patients are predicted by the nonspecificimmune response; specific immune response has only a systemic effect–a histopathological and immunohistochemical study. BMC Cancer 1:7CrossRefPubMedPubMedCentral
Zurück zum Zitat Pattison CW, Woods KL, Morrison JM (1987) Lymphocytopenia as an independent predictor of early recurrence in breast cancer. Br J Cancer 55(1):75–6CrossRefPubMedPubMedCentral Pattison CW, Woods KL, Morrison JM (1987) Lymphocytopenia as an independent predictor of early recurrence in breast cancer. Br J Cancer 55(1):75–6CrossRefPubMedPubMedCentral
Zurück zum Zitat Petrie HT, Klassen LW, Kay HD (1985) Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol 134(1):230–4PubMed Petrie HT, Klassen LW, Kay HD (1985) Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol 134(1):230–4PubMed
Zurück zum Zitat Said N, Theodorescu D (2012) RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment. Oncoimmunology 1(7):1175–1177CrossRefPubMedPubMedCentral Said N, Theodorescu D (2012) RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment. Oncoimmunology 1(7):1175–1177CrossRefPubMedPubMedCentral
Zurück zum Zitat Satomi A, Murakami S, Ishida K, Mastuki M, Hashimoto T, Sonoda M (1995) Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol 34(1):69–73CrossRefPubMed Satomi A, Murakami S, Ishida K, Mastuki M, Hashimoto T, Sonoda M (1995) Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol 34(1):69–73CrossRefPubMed
Zurück zum Zitat Schmeel LC, Schmeel FC, Coch C, Schmidt-Wolf IG (2015) Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC). J Cancer Res Clin Oncol 141(5):839–849CrossRefPubMed Schmeel LC, Schmeel FC, Coch C, Schmidt-Wolf IG (2015) Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC). J Cancer Res Clin Oncol 141(5):839–849CrossRefPubMed
Zurück zum Zitat SchmidtWolf IG, Negrin RS, Kiem HP, Blume KG, Weissman IL (1991) Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J Exp Med 174(1):139–49CrossRef SchmidtWolf IG, Negrin RS, Kiem HP, Blume KG, Weissman IL (1991) Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J Exp Med 174(1):139–49CrossRef
Zurück zum Zitat Shi L, Zhou Q, Wu J, Ji M, Li G, Jiang J, Wu C (2012) Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer. Cancer Immunol Immunother 61(12):2251–2259CrossRefPubMedPubMedCentral Shi L, Zhou Q, Wu J, Ji M, Li G, Jiang J, Wu C (2012) Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer. Cancer Immunol Immunother 61(12):2251–2259CrossRefPubMedPubMedCentral
Zurück zum Zitat Slaney CY, Kershaw MH, Darcy PK (2014) Trafficking of T cells into tumors. Cancer Res 74(24):7168–74CrossRefPubMed Slaney CY, Kershaw MH, Darcy PK (2014) Trafficking of T cells into tumors. Cancer Res 74(24):7168–74CrossRefPubMed
Zurück zum Zitat Stockmann C, Schadendorf D, Klose R, Helfrich I (2014) The impact of the immune system on tumor: angiogenesis and vascular remodeling. Front Oncol 4:69 Stockmann C, Schadendorf D, Klose R, Helfrich I (2014) The impact of the immune system on tumor: angiogenesis and vascular remodeling. Front Oncol 4:69
Zurück zum Zitat Sun S, Li X, Yu Z, Xu M, Liao Y, Zhang G (2016) The differences of the blood indicators between the healthy people and patients with lung cancer. J Mod Oncol ISSN 1672–4992 Sun S, Li X, Yu Z, Xu M, Liao Y, Zhang G (2016) The differences of the blood indicators between the healthy people and patients with lung cancer. J Mod Oncol ISSN 1672–4992
Zurück zum Zitat Takahashi T, Saikawa Y, Kitagawa Y (2013) Gastric cancer: current status of diagnosis and treatment. Cancers (Basel) 5(1):48–63CrossRef Takahashi T, Saikawa Y, Kitagawa Y (2013) Gastric cancer: current status of diagnosis and treatment. Cancers (Basel) 5(1):48–63CrossRef
Zurück zum Zitat Takahashi R, Mabuchi S, Kawano M et al (2015) Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study. Gynecol Oncol 137(1):112–118CrossRefPubMed Takahashi R, Mabuchi S, Kawano M et al (2015) Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study. Gynecol Oncol 137(1):112–118CrossRefPubMed
Zurück zum Zitat Wang SC, Chou JF, Strong VE, Brennan MF, Capanu M, Coit DG (2016) Pretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in resectable gastroesophageal junction and gastric adenocarcinoma. Ann Surg 263(2):292–297CrossRefPubMedPubMedCentral Wang SC, Chou JF, Strong VE, Brennan MF, Capanu M, Coit DG (2016) Pretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in resectable gastroesophageal junction and gastric adenocarcinoma. Ann Surg 263(2):292–297CrossRefPubMedPubMedCentral
Zurück zum Zitat Whiteside TL (2006) The role of immune cells in the tumor microenvironment. Cancer Treat Res 130:103–124CrossRefPubMed Whiteside TL (2006) The role of immune cells in the tumor microenvironment. Cancer Treat Res 130:103–124CrossRefPubMed
Metadaten
Titel
Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer
verfasst von
Yingchun Li
Chenyu Wang
Mengdan Xu
Cuicui Kong
Aibing Qu
Meng Zhang
Zhichao Zheng
Guirong Zhang
Publikationsdatum
20.01.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 5/2017
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-016-2330-1

Weitere Artikel der Ausgabe 5/2017

Journal of Cancer Research and Clinical Oncology 5/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.